Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

被引：0
|
作者：
Massimo Volpe
Alejandro de la Sierra
Bettina Ammentorp
Petra Laeis
机构：
[1] University of Rome “La Sapienza”,Division of Cardiology, Department of Clinical and Molecular Medicine
[2] Sant’Andrea Hospital,Department of Internal Medicine, Hospital Mutua Terrassa
[3] IRCCS Neuromed,undefined
[4] University of Barcelona,undefined
[5] Daiichi Sankyo Europe GmbH,undefined
来源：
Advances in Therapy | 2014年 / 31卷
关键词：
Cardiology; Hypertension; Olmesartan/amlodipine/hydrochlorothiazide; Open-label; Seated diastolic blood pressure; Seated systolic blood pressure; Triple combination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：561 / 574
页数：13
相关论文
共 50 条
  • [41] Long-term safety and efficacy of telmisartan/amlodipine single pill combination in the treatment of hypertension
    Billecke, Scott S.
    Marcovitz, Pamela A.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 95 - 104
  • [42] TRIPLE-COMBINATION TREATMENT WITH OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE IN HISPANIC/LATINO PATIENTS WITH HYPERTENSION: THE TRINITY STUDY
    Lewin, Andrew J.
    Kereiakes, Dean J.
    Chrysant, Steven G.
    Izzo, Joseph L., Jr.
    Oparil, Suzanne
    Lee, James
    Fernandez, Victor
    Melino, Michael
    ETHNICITY & DISEASE, 2014, 24 (01) : 41 - 47
  • [43] An open-label study of the safety and efficacy of triple-combination therapy of melasma in African-American patients
    Grimes, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P176 - P176
  • [44] Maintenance of long-term efficacy and safety of quetiapine in the open-label treatment of schizophrenia
    Kasper, S
    Brecher, M
    Fitton, L
    Jones, AM
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (05) : 281 - 289
  • [45] EFFICACY AND SAFETY OF OLMESARTAN AND OLMESARTAN PLUS HYDROCHLOROTHIAZIDE COMBINED WITH AMLODIPINE IN CHINESE PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION
    Li Hongwei
    Mei Kezhi
    Hua Qi
    Dai Qiuyan
    Peng Xiaoling
    Ding Hong
    Pi Lin
    Jin Zhimin
    Zhang Daifu
    Lv Ke
    Guo Xingui
    Xu Hui
    You Hua
    Yin Pengfei
    Yu Licheng
    Yang Ming
    Yu Xiaowei
    Naotaka, Ikegami
    Zhou Shuxian
    Gao Pingjin
    HEART, 2013, 99 : A61 - A62
  • [46] EFFICACY AND SAFETY OF COMBINATION OLMESARTAN MEDOXOMIL (OM) plus AMLODIPINE BESYLATE (AML) plus HYDROCHLOROTHIAZIDE (HCTZ) IN PATIENTS WITH HYPERTENSION: THE TRINITY STUDY
    Oparil, S.
    Melino, M.
    Fernandez, V.
    Lee, J.
    Heyrman, R.
    JOURNAL OF HYPERTENSION, 2010, 28 : E101 - E101
  • [47] Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy
    Tocci, Giuliano
    Paneni, Francesco
    Passerini, Jasmine
    Volpe, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (18) : 2687 - 2697
  • [48] Long term safety and efficacy of open-label infliximab for SLE
    Aringer, M.
    Houssiau, F.
    Graninger, W. B.
    Feier, E.
    Steiner, G.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 455 - 455
  • [49] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [50] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345